Literature DB >> 29519889

Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.

Chun Liu1,2,3, Angelos Oikonomopoulos1,2,3, Nazish Sayed1,2,3, Joseph C Wu4,2,3.   

Abstract

The advent of human induced pluripotent stem cells (iPSCs) presents unprecedented opportunities to model human diseases. Differentiated cells derived from iPSCs in two-dimensional (2D) monolayers have proven to be a relatively simple tool for exploring disease pathogenesis and underlying mechanisms. In this Spotlight article, we discuss the progress and limitations of the current 2D iPSC disease-modeling platform, as well as recent advancements in the development of human iPSC models that mimic in vivo tissues and organs at the three-dimensional (3D) level. Recent bioengineering approaches have begun to combine different 3D organoid types into a single '4D multi-organ system'. We summarize the advantages of this approach and speculate on the future role of 4D multi-organ systems in human disease modeling.
© 2018. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Disease modeling; Induced pluripotent stem cells; Organ-on-chip; Organoid

Mesh:

Year:  2018        PMID: 29519889      PMCID: PMC5868991          DOI: 10.1242/dev.156166

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  64 in total

Review 1.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

Authors:  Evangeline Tzatzalos; Oscar J Abilez; Praveen Shukla; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

2.  Human Astrocyte Maturation Captured in 3D Cerebral Cortical Spheroids Derived from Pluripotent Stem Cells.

Authors:  Steven A Sloan; Spyros Darmanis; Nina Huber; Themasap A Khan; Fikri Birey; Christine Caneda; Richard Reimer; Stephen R Quake; Ben A Barres; Sergiu P Paşca
Journal:  Neuron       Date:  2017-08-16       Impact factor: 17.173

3.  Modeling familial Alzheimer's disease with induced pluripotent stem cells.

Authors:  Takuya Yagi; Daisuke Ito; Yohei Okada; Wado Akamatsu; Yoshihiro Nihei; Takahito Yoshizaki; Shinya Yamanaka; Hideyuki Okano; Norihiro Suzuki
Journal:  Hum Mol Genet       Date:  2011-09-07       Impact factor: 6.150

4.  An Organoid-Based Model of Cortical Development Identifies Non-Cell-Autonomous Defects in Wnt Signaling Contributing to Miller-Dieker Syndrome.

Authors:  Vira Iefremova; George Manikakis; Olivia Krefft; Ammar Jabali; Kevin Weynans; Ruven Wilkens; Fabio Marsoner; Björn Brändl; Franz-Josef Müller; Philipp Koch; Julia Ladewig
Journal:  Cell Rep       Date:  2017-04-04       Impact factor: 9.423

5.  Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

Authors:  Ning Sun; Masayuki Yazawa; Jianwei Liu; Leng Han; Veronica Sanchez-Freire; Oscar J Abilez; Enrique G Navarrete; Shijun Hu; Li Wang; Andrew Lee; Aleksandra Pavlovic; Shin Lin; Rui Chen; Roger J Hajjar; Michael P Snyder; Ricardo E Dolmetsch; Manish J Butte; Euan A Ashley; Michael T Longaker; Robert C Robbins; Joseph C Wu
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

Review 6.  Engineering Stem Cell Organoids.

Authors:  Xiaolei Yin; Benjamin E Mead; Helia Safaee; Robert Langer; Jeffrey M Karp; Oren Levy
Journal:  Cell Stem Cell       Date:  2016-01-07       Impact factor: 24.633

7.  Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro.

Authors:  Jason R Spence; Christopher N Mayhew; Scott A Rankin; Matthew F Kuhar; Jefferson E Vallance; Kathryn Tolle; Elizabeth E Hoskins; Vladimir V Kalinichenko; Susanne I Wells; Aaron M Zorn; Noah F Shroyer; James M Wells
Journal:  Nature       Date:  2010-12-12       Impact factor: 49.962

8.  Modelling human development and disease in pluripotent stem-cell-derived gastric organoids.

Authors:  Kyle W McCracken; Emily M Catá; Calyn M Crawford; Katie L Sinagoga; Michael Schumacher; Briana E Rockich; Yu-Hwai Tsai; Christopher N Mayhew; Jason R Spence; Yana Zavros; James M Wells
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

9.  Retinal Organoids from Pluripotent Stem Cells Efficiently Recapitulate Retinogenesis.

Authors:  Manuela Völkner; Marlen Zschätzsch; Maria Rostovskaya; Rupert W Overall; Volker Busskamp; Konstantinos Anastassiadis; Mike O Karl
Journal:  Stem Cell Reports       Date:  2016-03-31       Impact factor: 7.765

10.  Development of a Three-Dimensional Bioengineering Technology to Generate Lung Tissue for Personalized Disease Modeling.

Authors:  Dan C Wilkinson; Jackelyn A Alva-Ornelas; Jennifer M S Sucre; Preethi Vijayaraj; Abdo Durra; Wade Richardson; Steven J Jonas; Manash K Paul; Saravanan Karumbayaram; Bruce Dunn; Brigitte N Gomperts
Journal:  Stem Cells Transl Med       Date:  2016-09-15       Impact factor: 6.940

View more
  77 in total

1.  Disease modelling and drug discovery for hypertrophic cardiomyopathy using pluripotent stem cells: how far have we come?

Authors:  Chi Keung Lam; Joseph C Wu
Journal:  Eur Heart J       Date:  2018-11-14       Impact factor: 29.983

2.  Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

Authors:  Sarah E Lee; Monica Duran-Martinez; Sabina Khantsis; Diana W Bianchi; Faycal Guedj
Journal:  Trends Mol Med       Date:  2019-11-07       Impact factor: 11.951

3.  An isogenic hiPSC-derived BBB-on-a-chip.

Authors:  Pedram Motallebnejad; Andrew Thomas; Sarah L Swisher; Samira M Azarin
Journal:  Biomicrofluidics       Date:  2019-11-22       Impact factor: 2.800

4.  Identifying the Transcriptome Signatures of Calcium Channel Blockers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Chi Keung Lam; Lei Tian; Nadjet Belbachir; Alexa Wnorowski; Rajani Shrestha; Ning Ma; Tomoya Kitani; June-Wha Rhee; Joseph C Wu
Journal:  Circ Res       Date:  2019-05-13       Impact factor: 17.367

Review 5.  A human-on-a-chip approach to tackling rare diseases.

Authors:  Camilly P Pires de Mello; John Rumsey; Victoria Slaughter; James J Hickman
Journal:  Drug Discov Today       Date:  2019-08-11       Impact factor: 7.851

Review 6.  Mechanical influences on cardiovascular differentiation and disease modeling.

Authors:  Evan L Teng; Adam J Engler
Journal:  Exp Cell Res       Date:  2019-02-19       Impact factor: 3.905

7.  Comparative Transcriptomic Analysis of Cerebral Organoids and Cortical Neuron Cultures Derived from Human Induced Pluripotent Stem Cells.

Authors:  Annie Kathuria; Kara Lopez-Lengowski; Bradley Watmuff; Rakesh Karmacharya
Journal:  Stem Cells Dev       Date:  2020-09-22       Impact factor: 3.272

8.  Strategies for Improving the Maturity of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Chengyi Tu; Benjamin S Chao; Joseph C Wu
Journal:  Circ Res       Date:  2018-08-17       Impact factor: 17.367

9.  Defining the Teratoma as a Model for Multi-lineage Human Development.

Authors:  Daniella McDonald; Yan Wu; Amir Dailamy; Justin Tat; Udit Parekh; Dongxin Zhao; Michael Hu; Ann Tipps; Kun Zhang; Prashant Mali
Journal:  Cell       Date:  2020-11-04       Impact factor: 41.582

Review 10.  Induced pluripotent stem cells as a platform to understand patient-specific responses to opioids and anaesthetics.

Authors:  Detlef Obal; Joseph C Wu
Journal:  Br J Pharmacol       Date:  2020-08-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.